MYCN is a potent cancer-causing gene, and its elevated activity drives the initiation, progression, and treatment resistance of a broad spectrum of childhood cancers. Neuroblastoma is the most common extracranial solid tumor among children, with approximately half of them characterized as high-risk, which spread to distant organs rapidly and result in less than 50% survival rates.